NOVA1 antibody (C-Term)
Quick Overview for NOVA1 antibody (C-Term) (ABIN2743301)
Target
See all NOVA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Brand
- IHC-plus™
-
Specificity
- Human NOVA1
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Recombinant protein encompassing a sequence within the C-terminus region of human NOVA1.
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: ICC (1:100 - 1:1000), IHC, IHC-P (10 μg/mL), WB (1:500 - 1:3000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1 M Tris-glycine, pH 7.0, 10 % glycerol, 0.01 % Thimerosal
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid multiple freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- NOVA1 (Neuro-Oncological Ventral Antigen 1 (NOVA1))
-
Alternative Name
- NOVA1
-
Background
-
Name/Gene ID: NOVA1
Synonyms: NOVA1, Nova-1, Onconeural ventral antigen 1, RNA-binding protein Nova-1, Paraneoplastic Ri antigen -
Gene ID
- 4857
Target
-